PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CXCL9 1,016 Target Target CXCL4/PF4 9 2 0.02 -0.88 0.22 0.72
Colon Cancer 30,064 Disease Drug Doxazolidine 9 2 0.00 -0.88 0.22 0.63
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
Cox-2 21,583 Target Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.62
BLyS 457 Target Target CD254 9 1 0.02 -0.94 0.11 0.73
Tuberculosis 146,217 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.58
CCL3 1,427 Target Target CXCL4/PF4 9 3 0.03 -0.82 0.33 0.72
Aminocaproic Acid (Amicar)- FDA 5 Drug Drug Aprotinin (Trasylol)- FDA 9 2 0.30 -0.68 0.40 0.92
Skin Cancer 11,561 Disease Target CD254 9 1 0.00 -0.94 0.11 0.63
Glomerulonephritis 23,459 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.62
Androgen Receptor 12,918 Target Drug Doxorubicin-Formaldehyde Conjugate 9 2 0.01 -0.88 0.22 0.65
Sarcoidosis 19,176 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.62
CXCL7 76 Target Target CXCL4/PF4 9 1 0.04 -0.94 0.11 0.79
CD137 474 Target Target CD254 9 1 0.02 -0.94 0.11 0.72
Leukemia 162,805 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.57
Hemorrhage 100,979 Disease Drug Aprotinin (Trasylol)- FDA 9 1 0.00 -0.94 0.11 0.58
Rheumatoid Arthritis 78,952 Disease Target CD254 9 1 0.00 -0.94 0.11 0.59
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxoform 9 4 0.44 -0.56 0.44 0.95
Cancer 1,053,491 Disease Drug Doxoform 9 8 0.00 -0.33 0.89 0.58
Cancer 1,053,491 Disease Target CD254 9 2 0.00 -0.88 0.22 0.55
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
Retinitis 9,116 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.64
Cancer 1,053,491 Disease Target CXCL4/PF4 9 2 0.00 -0.88 0.22 0.55
Colon Cancer 30,064 Disease Drug Doxorubicin-Formaldehyde Conjugate 9 1 0.00 -0.94 0.11 0.61
Cancer 1,053,491 Disease Drug Doxazolidine 9 8 0.00 -0.33 0.89 0.58
CCL2 3,560 Target Target CXCL4/PF4 9 2 0.01 -0.88 0.22 0.68
Carcinoma 433,099 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.56
Glaucoma 41,465 Disease Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.60
CD68 6,424 Target Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.65
Infection 766,637 Disease Target CINC-2- alpha 9 1 0.00 -0.94 0.11 0.54
Amicar (Aminocaproic Acid)- FDA 5 Drug Drug Aprotinin (Trasylol)- FDA 9 2 0.30 -0.68 0.40 0.92
CCL4 5,638 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.65
Doxoform 9 Drug Drug Doxazolidine 9 2 0.22 -0.78 0.22 0.92
CCL19 658 Target Target CXCL4/PF4 9 1 0.01 -0.94 0.11 0.71
Diabetes 332,602 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.56
Prostate Cancer 71,064 Disease Drug Doxoform 9 2 0.00 -0.88 0.22 0.61
BAFF 1,240 Target Target CD254 9 2 0.02 -0.88 0.22 0.72
Endoglin 1,333 Target Target CD254 9 1 0.01 -0.94 0.11 0.69
Prostate Cancer 71,064 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.59
Infection 766,637 Disease Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.54
Obesity 138,233 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.58
Breast Cancer 173,695 Disease Drug Doxazolidine 9 1 0.00 -0.94 0.11 0.57
Collagen 138,882 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.58
Doxorubicin-Formaldehyde Conjugate 9 Drug Drug Doxazolidine 9 2 0.22 -0.78 0.22 0.92
bFGF 9,327 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.64
Diabetes 332,602 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.56
Dromostanolone Propionate 3 Drug Drug Dromostanolone 8 3 0.61 -0.41 1.00 0.95
Major Depressive Disorder 12,517 Disease Drug Alprazolam (Xanax)- FDA 8 1 0.00 -0.94 0.12 0.63
CCL21 808 Target Target Exodus-3 8 1 0.01 -0.93 0.12 0.71
Aldactone (Spironolactone)- FDA 18 Drug Drug Alprazolam (Xanax)- FDA 8 2 0.17 -0.82 0.25 0.88